Hasan, A.U.; Sato, S.; Obara, M.; Kondo, Y.; Taira, E.
HDAC5 Inhibition as a Therapeutic Strategy for Titin Deficiency-Induced Cardiac Remodeling: Insights from Human iPSC Models. Medicines 2025, 12, 26.
https://doi.org/10.3390/medicines12040026
AMA Style
Hasan AU, Sato S, Obara M, Kondo Y, Taira E.
HDAC5 Inhibition as a Therapeutic Strategy for Titin Deficiency-Induced Cardiac Remodeling: Insights from Human iPSC Models. Medicines. 2025; 12(4):26.
https://doi.org/10.3390/medicines12040026
Chicago/Turabian Style
Hasan, Arif Ul, Sachiko Sato, Mami Obara, Yukiko Kondo, and Eiichi Taira.
2025. "HDAC5 Inhibition as a Therapeutic Strategy for Titin Deficiency-Induced Cardiac Remodeling: Insights from Human iPSC Models" Medicines 12, no. 4: 26.
https://doi.org/10.3390/medicines12040026
APA Style
Hasan, A. U., Sato, S., Obara, M., Kondo, Y., & Taira, E.
(2025). HDAC5 Inhibition as a Therapeutic Strategy for Titin Deficiency-Induced Cardiac Remodeling: Insights from Human iPSC Models. Medicines, 12(4), 26.
https://doi.org/10.3390/medicines12040026